Comparison of denatured growth factor proteins from heat manufacturing versus biologically active ADSC-CM preserved by Cold Process in Majestic Skin Serum

Why Most Growth Factor Serums Fail (And How to Find One That Works)

Written and Reviewed by Dr. Kenji Tanaka, Lead Researcher, Majestic Cosme Laboratories
Published Date: May 21, 2026
You invested in a premium growth factor serum. You followed the instructions. You waited the prescribed weeks. And the result was either negligible or barely noticeable. If this experience sounds familiar, the problem almost certainly was not your skin. It was the serum. Specifically, it was two engineering problems that the majority of growth factor serums on the market have never solved.

The Billion-Dollar Promise vs. The Biological Reality

The growth factor serum market is built on a genuine scientific foundation. Growth factors, the signaling proteins that direct skin cells to produce collagen, elastin, and hyaluronic acid, are real, well-studied molecules with documented roles in skin regeneration. The clinical evidence for their efficacy when they reach their biological targets is consistent and compelling.

The gap between the promise and the reality is not a failure of the science. It is a failure of delivery. Two specific engineering problems prevent the vast majority of growth factor serums from doing what their ingredient lists imply. Understanding these problems is the first step toward finding a product that has actually solved them.

Point of Failure One: The Heat Problem That Destroys Potency

Growth factors are proteins. And like all proteins, they are exquisitely sensitive to heat. This is not a fringe observation; it is fundamental chemistry.

Structural Denaturation Analogy

Think of a raw egg white. It is a clear, viscous liquid, biologically active and structurally intact. Apply heat to it and within seconds it becomes an opaque, rubbery solid. The egg white has not lost its chemical components. But the precise three-dimensional structure that gave it biological function has been permanently destroyed. This is denaturation, and it happens to growth factor proteins under exactly the same conditions.

Standard cosmetic manufacturing is a heat-intensive process. Emulsification, sterilisation, and blending all require elevated temperatures, typically between 60 and 90 degrees Celsius. At these temperatures, growth factor proteins lose the precise molecular folding that allows them to bind to cell surface receptors and trigger the biological response that justifies their inclusion in the formula.

A serum manufactured with heat that lists growth factors on the ingredient label is, in many cases, listing proteins that are no longer biologically functional by the time the product reaches the consumer. The label is technically accurate. The activity is not.

1

The Heat Gaps Matrix

Standard manufacturing temperatures between 60 and 90 degrees Celsius denature growth factor proteins, destroying the precise molecular structure that allows them to bind to fibroblast receptors. A serum produced with heat may list growth factors on its label while delivering proteins that are biologically inactive.

Point of Failure Two: The Delivery Problem That Blocks Results

Assume for a moment that a serum has successfully preserved its growth factors in biologically active form. A second fundamental problem remains: getting them through the skin barrier.

The stratum corneum, the outermost layer of skin, is an extraordinarily effective barrier. It evolved over millions of years to keep substances out, and it performs this function with impressive consistency. The general rule in cosmetic science is that molecules above approximately 500 daltons in molecular weight cannot passively penetrate through intact skin. Growth factor proteins range from 6,000 to over 25,000 daltons.

This means that even a perfectly preserved, biologically active growth factor applied to the skin surface will remain largely at the surface. It cannot reach the dermal fibroblasts, located 1 to 4 millimetres below the surface, where collagen synthesis occurs. The best anti-aging serum for wrinkles in the world is of no structural benefit if its active ingredients never reach the cells that need to receive them.

2

The Penetration Threshold Gap

Growth factor proteins range from 6,000 to 25,000+ daltons in molecular weight. The skin barrier's general passive permeability threshold is approximately 500 daltons. Without a dedicated delivery mechanism, growth factors sit on the skin's surface, unable to reach the dermal fibroblasts where they need to act.

The Japanese Standard: A Dual-Solution for True Efficacy

These are not new problems. They have been understood in pharmaceutical and cosmetic science for decades. What is relatively new is their solution at the manufacturing scale and quality required for a consumer-grade product to deliver clinical-level results.

Majestic Skin was developed to address both failure points simultaneously: a proprietary Cold Process manufacturing protocol that preserves the biological integrity of all 150+ growth factors, and Liposome Technology that delivers those preserved proteins past the epidermal barrier to the fibroblasts in the dermis.

The Thermal Deficit
Heat during manufacturing denatures growth factor proteins. Conventional serums list active ingredients that are biologically inactive by the time of application.
The Cold Process Architecture
Cold Process formulation: no heat applied at any manufacturing stage. All 150+ growth factors retain full three-dimensional structure and receptor-binding activity from production to application.
The Permeability Barrier
Growth factor molecules are too large to passively penetrate the skin barrier. They remain at the surface, unable to reach the fibroblasts in the dermis where structural repair occurs.
The Phospholipid Liposome System
Liposome Technology: growth factors are encapsulated in lipid vesicles structurally compatible with cell membranes, enabling controlled dermal penetration to fibroblast receptor sites.

The combination of these two solutions defines the difference between a growth factor serum that performs as a premium moisturiser and one that delivers the fibroblast-level biological activity that produces structural skin improvement. Both solutions are necessary. Solving only one of the two failure points produces a serum with either intact proteins that cannot penetrate, or a delivery mechanism carrying denatured proteins that cannot bind.

How Our Cold Process Protects 150+ Bio-Active Growth Factors

Cold Process manufacturing eliminates heat from every stage of production. In conventional cosmetic manufacturing, this represents a significant engineering challenge: blending, sterilisation, and preservation all typically rely on elevated temperatures. The Cold Process protocol developed for Majestic Skin replaces heat-dependent processes with low-temperature alternatives at every stage.

The ADSC-CM (adipose-derived stem cell conditioned medium) at the core of Majestic Skin contains over 150 active growth factor proteins collected from the secretory output of human adipose stem cells during pharmaceutical-grade GMP culture in Japan. This conditioned medium contains EGF, FGF, TGF-beta, VEGF, IGF, and over 145 additional signaling proteins and cytokines.

Each of these proteins maintains its biological activity only in its correctly folded three-dimensional conformation. Cold Process manufacturing is the only method that guarantees this conformation is preserved throughout production, packaging, and delivery to the consumer. Third-party testing verifies the biological activity of every batch before release.

The practical implication of Cold Process manufacturing is that what the ingredient label states at 20% ADSC-CM concentration is what the consumer receives at the point of application: 20% biologically active conditioned medium, not 20% of proteins that have been rendered inert by the manufacturing process.

Liposome Encapsulation: Unlocking Deeper Skin Penetration

A liposome is a spherical vesicle composed of one or more phospholipid bilayers, identical in structure to the membrane surrounding every living cell in the body. This structural compatibility is the key to liposome technology's effectiveness as a delivery system.

When a liposome encounters the lipid bilayer of the stratum corneum, it can fuse with it, releasing its encapsulated contents into the layer below. Through successive membrane fusion events as it travels deeper through the skin layers, the liposome carries its payload toward the dermis.

  1. Growth factors are encapsulated within phospholipid liposome vesicles during Cold Process formulation. The encapsulation protects the proteins from environmental degradation as well as providing the delivery mechanism.
  2. Applied to the skin surface, the liposomes contact the stratum corneum. Their phospholipid structure is chemically compatible with the skin barrier's lipid composition, enabling penetration rather than surface retention.
  3. The liposomes traverse the epidermis through the intercellular lipid pathways, bypassing the size restriction that prevents passive diffusion of large molecules like growth factors.
  4. Growth factors are released at the dermal level, where they bind to receptors on fibroblast surfaces and initiate the collagen synthesis cascade that produces structural skin improvement.

The pharmaceutical science underlying liposome drug delivery is well established, with decades of clinical application in targeted therapeutic contexts. Majestic Skin applies this technology to the cosmetic delivery problem that has limited growth factor serums since the category emerged. For a deeper understanding of how this specific structural delivery advantage performs relative to separate marine signaling developments, our clinical verification of PDRN vs human stem cell serum provides an evaluation of how different baseline technologies manage the molecular barrier problem.

The Unbroken Chain of Efficacy Matrix

Manufacturing Approach Growth Factor Integrity Status Dermal Penetration Metrics
Conventional heat manufacturing, no delivery system Denatured by thermal processing Surface layer retention only
Heat manufacturing with liposome delivery Denatured before encapsulation phase Liposomes traverse epidermal layers carrying inactive cargo
Cold Process, no delivery architecture Fully intact original folding Surface layer retention only
Cold Process + Liposome System (Majestic Skin) Fully intact native conformation Complete delivery to dermal fibroblasts

Clinical data on Majestic Skin's formula confirms the expected outcome of this engineering: the formula induces a larger volume of hyaluronan expression than even positive control groups treated with isolated growth factors in laboratory settings. This result reflects fibroblast-level biological activity, not surface hydration, and is only achievable when both integrity and penetration problems have been solved simultaneously. The technology underpinning this approach is part of a broader shift in Japanese skincare innovation, as our report on the rise of Japanese skincare technology contextualises Majestic Skin within the wider landscape of Japanese biotech advances in skincare science.

Choosing the Best Anti-Aging Serum for Wrinkles: What to Look For

For consumers who have previously been disappointed by growth factor serums, the following clinical parameters identify whether a product has addressed the primary cellular failure points.

  • Manufacturing temperature verification If a brand does not disclose its manufacturing temperature protocol, assume standard heat-based production. The absence of this information is itself informative. Majestic Skin publishes its Cold Process methodology as a core differentiator, not a footnote.
  • Delivery matrix specification Growth factors listed without a delivery system are likely surface-acting only. A credible product in this category names its delivery mechanism and explains how it overcomes the molecular weight barrier.
  • Human secretome vs plant stem cell markers Plant stem cell extracts are antioxidant-rich but contain no human growth factors capable of signaling fibroblasts. The INCI name should specify human adipose-derived conditioned medium or equivalent human-origin designation.
  • Disclosed secretome density threshold Concentration below 5% is unlikely to produce measurable fibroblast stimulation. Majestic Skin's 20% concentration is verified by third-party testing and represents one of the highest commercially available from a Japanese pharmaceutical-grade source.
  • Multi-market regulatory compliance profiles JCIA registration, BPOM approval, or equivalent multi-market regulatory status indicates the product has been subjected to external quality and safety assessment, not only internal brand claims.

By these criteria, most growth factor serums currently on the market fail at the first or second checkpoint. For those who want a more detailed examination of how this technology sits alongside other approaches to clinical-level wrinkle treatment, the comparison of stem cell face serum vs Botox examines the full spectrum of options with clinical evidence.

Conclusion

The compound effect of Cold Process manufacturing and Liposome Technology produces an unbroken chain of efficacy: growth factors that are biologically active when they leave the laboratory, and delivery technology that places them at the receptor sites where they can act. Choosing an anti-aging solution requires verifying the presence of these necessary parameters. Without thermal protection and cellular vesicular systems, proteins remain an expensive surface treatment rather than an active dermal agent. By demanding pharmaceutical manufacturing thresholds, consumers can bridge the gap between commercial marketing claims and verified biological outcomes, waking up the skin structure factories where real regeneration occurs.

Medical Disclaimer This scientific text is provided for educational and informational parameters only and does not constitute medical advice, diagnosis, or clinical recommendation. Individual cellular output and fibroblast response cycles may vary according to native tissue health baselines. Consult a board-certified professional prior to regimen alteration. Parameters referenced reflect empirical parameters derived from controlled testing of Majestic Skin Serum arrays.

Frequently Asked Questions

How can I tell if a growth factor serum I already own was made with heat?
Most brands do not proactively disclose manufacturing temperature. The most reliable signal is the explicit absence of a cold process or low-temperature manufacturing claim. If the brand does not prominently mention how it preserves its growth factors during production, it almost certainly uses standard heat-based manufacturing. You can also contact the brand directly and ask whether their formulation process involves any heating above 40 degrees Celsius. A brand that has solved the heat problem will know the answer immediately and answer it confidently.
Is liposome delivery technology the only way to get growth factors into the dermis?
Liposome encapsulation is the most established and clinically validated method for topical growth factor delivery. Other approaches exist, including ethosomes, niosomes, and microneedle-assisted delivery, but most have either less clinical evidence in the cosmetic context, higher cost of manufacture, or practical limitations for daily consumer use. Pharmaceutical-grade liposomes, produced under controlled conditions with precise phospholipid composition, represent the current gold standard for non-invasive topical growth factor delivery to the dermis.
Why do most brands not use Cold Process manufacturing if it produces better results?
Cold Process manufacturing at pharmaceutical-grade scale is significantly more complex and expensive than conventional heat-based production. It requires specialised equipment, tighter environmental controls, and more rigorous quality testing at each production stage. For brands producing high volumes at competitive price points, the cost of Cold Process manufacturing is prohibitive. Majestic Skin's positioning as a pharmaceutical-grade Japanese biotech product, with corresponding production standards, reflects a deliberate decision to prioritise biological efficacy over production cost efficiency.
Does the 20% ADSC-CM concentration matter if the growth factors reach the dermis via liposomes?
Yes. Concentration determines the strength of the biological signal at the receptor level. Growth factor signaling in skin follows a dose-response relationship: below a threshold concentration, fibroblast stimulation is insufficient to produce measurable collagen output. The published clinical evidence for meaningful collagen density improvement with topical ADSC-CM is concentrated at 15% and above. At 20%, Majestic Skin delivers both the delivery mechanism and the signal strength required for clinical-level fibroblast activation. A product with a perfect liposome delivery system carrying a 2% ADSC-CM payload will produce a weaker fibroblast response than the same delivery system at 20%.
If I've been using a conventional growth factor serum, will switching to Majestic Skin produce dramatic changes?
Users switching from conventional growth factor serums to Majestic Skin frequently report more pronounced improvement than they experienced previously, which is consistent with what the engineering differences predict. If the previous serum was heat-manufactured without a delivery system, it was likely providing surface hydration and minimal biological activity at the dermal level. A 14-day Majestic Skin cycle provides the full fibroblast-level signal for the first time, producing the collagen synthesis activity and accelerated renewal that the previous product implied but could not deliver.
The Intelligent Choice for Proven Efficacy

Majestic Skin Serum

Cold Process formulation. Liposome deep delivery. 20% ADSC-CM. 150+ biologically active growth factors. JCIA registered. The only growth factor serum that solves both fundamental structural delivery problems.

Shop Majestic Skin Now

Scientific References

  1. Shin, H., et al. (2021). Human adipose tissue-derived mesenchymal stem cells and their secretome exert anti-aging properties in human skin. Biomolecules, 11(11), 1684.
  2. Kober, M., & Berto, G. (2022). Adipose-derived stem cell conditioned medium in the treatment of facial skin aging. Journal of Cosmetic Dermatology, 21(4), 1421-1431.
  3. Dragicevic, N., & Maibach, H. I. (Eds.). (2018). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer. (Chapter: Lipid-Based Drug Delivery Systems for Skin).
  4. Benson, H. A. E. (2006). Transfersomes for transdermal drug delivery. Expert Opinion on Drug Delivery, 3(6), 727-737.
  5. Kim, W. S., et al. (2009). Wound healing effect of adipose-derived stem cells: A critical role of secretory factors on fibroblast collagen synthesis. Journal of Dermatological Science, 55(3), 187-197.
ブログに戻る

コメントを残す

コメントは公開前に承認される必要があることにご注意ください。